Amyloidosis Research Consortium, Inc.
The Amyloidosis Research Consortium (ARC) is a global nonprofit organization dedicated to improving survival rates and quality of life for people diagnosed with systemic amyloidosis. We address the unmet needs of patients by investing in rigorous research that can save lives; we raise awareness of the disease for an earlier diagnosis and empower patients with information that helps them access the best care possible.